Thailand plans November human testing for potential coronavirus vaccine
Facilities in San Diego and Vancouver will produce 10,000 doses for the trials for 5,000 people. The first group, aged 18 to 60, will receive different doses of the vaccine
Facilities in San Diego and Vancouver will produce 10,000 doses for the trials for 5,000 people. The first group, aged 18 to 60, will receive different doses of the vaccine